Matches in SemOpenAlex for { <https://semopenalex.org/work/W2765219927> ?p ?o ?g. }
- W2765219927 endingPage "14" @default.
- W2765219927 startingPage "5" @default.
- W2765219927 abstract "Direct-acting antivirals (DAAs), which target hepatitis C virus (HCV) proteins, have exhibited impressive efficacy in the management of chronic hepatitis C. However, the concerns regarding high costs, drug resistance mutations and subsequent unexpected side effects still call for the development of host-targeting agents (HTAs) that target host factors involved in the viral life cycle and exhibit pan-genotypic antiviral activity. Given the close relationship between lipid metabolism and the HCV life cycle, we investigated the anti-HCV activity of a series of lipid-lowering drugs that have been approved by government administrations or proven safety in clinical trials. Our results showed that avasimibe, an inhibitor of acyl coenzyme A:cholesterol acyltransferase (ACAT), exhibited marked pan-genotypic inhibitory activity and superior inhibition against HCV when combined with DAAs. Moreover, avasimibe significantly impaired the assembly of infectious HCV virions. Mechanistic studies demonstrated that avasimibe induced downregulation of microsomal triglyceride transfer protein expression, resulting in reduced apolipoprotein E and apolipoprotein B secretion. Therefore, the pan-genotypic antiviral activity and clinically proven safety endow avasimibe exceptional potential as a candidate for combination therapy with DAAs. In addition, the discovery of the antiviral properties of ACAT inhibitors also suggests that inhibiting the synthesis of cholesteryl esters might be an additional target for the therapeutic intervention for chronic HCV infection." @default.
- W2765219927 created "2017-11-10" @default.
- W2765219927 creator A5011986143 @default.
- W2765219927 creator A5024724996 @default.
- W2765219927 creator A5026249336 @default.
- W2765219927 creator A5049169444 @default.
- W2765219927 creator A5054804924 @default.
- W2765219927 creator A5066906211 @default.
- W2765219927 creator A5069988164 @default.
- W2765219927 creator A5071761552 @default.
- W2765219927 creator A5073985584 @default.
- W2765219927 date "2017-12-01" @default.
- W2765219927 modified "2023-10-10" @default.
- W2765219927 title "Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles" @default.
- W2765219927 cites W1504020539 @default.
- W2765219927 cites W1791855926 @default.
- W2765219927 cites W1821737351 @default.
- W2765219927 cites W1922641266 @default.
- W2765219927 cites W1960714685 @default.
- W2765219927 cites W1970828145 @default.
- W2765219927 cites W1978130780 @default.
- W2765219927 cites W1980805512 @default.
- W2765219927 cites W1982370923 @default.
- W2765219927 cites W1985518121 @default.
- W2765219927 cites W1986505810 @default.
- W2765219927 cites W1993281511 @default.
- W2765219927 cites W1994879221 @default.
- W2765219927 cites W1997385930 @default.
- W2765219927 cites W2000055910 @default.
- W2765219927 cites W2001163111 @default.
- W2765219927 cites W2006418769 @default.
- W2765219927 cites W2013018952 @default.
- W2765219927 cites W2015489330 @default.
- W2765219927 cites W2016679900 @default.
- W2765219927 cites W2022557944 @default.
- W2765219927 cites W2024763248 @default.
- W2765219927 cites W2056724322 @default.
- W2765219927 cites W2067685971 @default.
- W2765219927 cites W2075782647 @default.
- W2765219927 cites W2079599967 @default.
- W2765219927 cites W2094733152 @default.
- W2765219927 cites W2104010560 @default.
- W2765219927 cites W2105291849 @default.
- W2765219927 cites W2110842901 @default.
- W2765219927 cites W2112500834 @default.
- W2765219927 cites W2127274349 @default.
- W2765219927 cites W2132874997 @default.
- W2765219927 cites W2133036275 @default.
- W2765219927 cites W2135999578 @default.
- W2765219927 cites W2144449254 @default.
- W2765219927 cites W2145702313 @default.
- W2765219927 cites W2147684303 @default.
- W2765219927 cites W2151898297 @default.
- W2765219927 cites W2154754322 @default.
- W2765219927 cites W2157465942 @default.
- W2765219927 cites W2160788656 @default.
- W2765219927 cites W2166885072 @default.
- W2765219927 cites W2168763691 @default.
- W2765219927 cites W2299840252 @default.
- W2765219927 cites W2302595440 @default.
- W2765219927 cites W2410570680 @default.
- W2765219927 cites W2415824834 @default.
- W2765219927 cites W2465812905 @default.
- W2765219927 cites W2468776796 @default.
- W2765219927 cites W2521424512 @default.
- W2765219927 cites W2523747565 @default.
- W2765219927 cites W2565410143 @default.
- W2765219927 cites W2589461577 @default.
- W2765219927 cites W2591108500 @default.
- W2765219927 doi "https://doi.org/10.1016/j.antiviral.2017.10.016" @default.
- W2765219927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29074218" @default.
- W2765219927 hasPublicationYear "2017" @default.
- W2765219927 type Work @default.
- W2765219927 sameAs 2765219927 @default.
- W2765219927 citedByCount "12" @default.
- W2765219927 countsByYear W27652199272018 @default.
- W2765219927 countsByYear W27652199272019 @default.
- W2765219927 countsByYear W27652199272021 @default.
- W2765219927 countsByYear W27652199272022 @default.
- W2765219927 countsByYear W27652199272023 @default.
- W2765219927 crossrefType "journal-article" @default.
- W2765219927 hasAuthorship W2765219927A5011986143 @default.
- W2765219927 hasAuthorship W2765219927A5024724996 @default.
- W2765219927 hasAuthorship W2765219927A5026249336 @default.
- W2765219927 hasAuthorship W2765219927A5049169444 @default.
- W2765219927 hasAuthorship W2765219927A5054804924 @default.
- W2765219927 hasAuthorship W2765219927A5066906211 @default.
- W2765219927 hasAuthorship W2765219927A5069988164 @default.
- W2765219927 hasAuthorship W2765219927A5071761552 @default.
- W2765219927 hasAuthorship W2765219927A5073985584 @default.
- W2765219927 hasConcept C13028836 @default.
- W2765219927 hasConcept C140704245 @default.
- W2765219927 hasConcept C159047783 @default.
- W2765219927 hasConcept C2522874641 @default.
- W2765219927 hasConcept C25897203 @default.
- W2765219927 hasConcept C2776408679 @default.
- W2765219927 hasConcept C2778163477 @default.
- W2765219927 hasConcept C2779756493 @default.